Furthermore, authors reported that TMZ resistance may be acquired in vivo in chemoresponsive GBM areas by SBF2-AS1-enriched exosomes, produced by the intrinsic population of tumourigenic cells [119]. Here, SBF2 is linked to glioblastoma.